Skip to main content

Kashmolah Ghazi's Form 4/A amendment

Amended

Lucira Health, Inc. (LHDX) · filed Aug 24, 2022

Accession no.
0001209191-22-047309
Filed
Aug 24, 2022
Trade date
Aug 17-18, 2022
Filing delay
7 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Aug 19, 2022

This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $55.9K. It was filed 7 days after the trade.

This amendment replaces 0001209191-22-046962 (filed Aug 19, 2022).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kashmolah GhaziCIK 0001877741Officer (Ex VP & Chief Quality Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 18, 2022Common StockSSaleDisposed−3,500$2.25−$7,875177,257Direct
Aug 17, 2022Common StockSSaleDisposed−19,074$2.52−$48,066.48180,757Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)